Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Cancer thermal therapy, commonly called hyperthermia, is a treatment that uses heat to target and destroy cancer cells. In everyday medical language, it means raising the temperature of tumor tissue to damage or kill cancer cells while trying to protect the healthy tissue around the tumor. This heat can be applied using different technologies such as radiofrequency ablation, microwave ablation, or high-intensity focused ultrasound. These methods deliver heat directly to the tumor to shrink or eliminate it.
Heat can make cancer cells more vulnerable and sometimes improve the effects of other treatments like chemotherapy or radiation. Because of this, hyperthermia is often used alongside these treatments to help shrink tumors or make cancer cells easier to kill. However, hyperthermia has limitations. It can be difficult to treat large tumors completely with heat alone, and there is a risk of damaging nearby healthy tissues. To overcome these challenges, researchers are developing special materials that help focus the heat more precisely on tumors and increase the tumor’s sensitivity to heat. Some of these materials can also deliver medicines or immune-boosting agents directly to the tumor, combining heat therapy with other treatments to improve effectiveness.
Patients may hear about hyperthermia as part of a treatment plan or clinical trial. They might be told that it involves heating the tumor area using specialized equipment and that it can be combined with chemotherapy, radiation, or immunotherapy. The treatment is usually done in a controlled way to avoid harming healthy tissue. Patients may feel warmth or mild discomfort during the procedure, but experiences can vary. It is important to understand that hyperthermia is not a standalone cure for most cancers but can be part of a broader treatment strategy.
The term hyperthermia or cancer thermal therapy may appear in medical reports, treatment plans, visit notes, or clinical trial descriptions. It may also be mentioned in discussions about combining treatments or in research studies exploring new ways to improve cancer care. Seeing the term in these contexts usually means the care team is considering or using heat-based treatment as one part of the overall cancer care approach.
Hearing about hyperthermia does not mean that all tumors will be completely destroyed by heat alone or that side effects will be fewer. It is one tool among many in cancer treatment and is not a guaranteed cure. It also does not mean that the treatment is widely available or standard for every type of cancer. The effectiveness and safety depend on many factors, including tumor size, location, and the patient’s overall health.
If hyperthermia is mentioned as a possible treatment, it is helpful to ask how it fits into your specific treatment plan. Questions might include what the procedure involves, what side effects to expect, how it works with other treatments, and whether there are clinical trials or newer technologies available. Understanding these details can help you make informed decisions and feel more comfortable with your care.
Reading about hyperthermia in the context of your treatment plan or clinical trial helps clarify its role as a complementary therapy rather than a replacement for other treatments. Because hyperthermia can be complex, it is normal to have questions or concerns. Discussing these openly with your oncology team is the best way to understand how this treatment might benefit you.
This information is for education and does not replace personalized medical advice. Treatment decisions depend on many factors unique to each person. If hyperthermia is part of your care discussion, the next sensible step is to talk with your oncology team about how it might help your specific cancer type and stage, what the procedure involves, and what outcomes to expect. Asking about clinical trials or new technologies related to hyperthermia can also be useful if you are interested in advanced treatment options.
Public source information used for this glossary entry includes: